RT-PCR results also demonstrated that the addition of AUY922 resulted in lower mRNA expression levels of VEGFR1 and VEGFR2 in renal cancer cells compared to treatment with sunitinib alone (Fig. 6E and F). This evidence concerns the gene FLT1 and renal carcinoma.